Almeda Ventures Limited Partnership (TLV:AMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 188.30
-5.00 (-2.59%)
At close: Apr 24, 2026
TLV:AMDA Revenue
In the year 2025, Almeda Ventures Limited Partnership had annual revenue of $2.47M USD. Almeda Ventures Limited Partnership had revenue of $3.45M in the half year ending December 31, 2025, with 19,066.67% growth.
Revenue
$2.47M
Revenue Growth
n/a
P/S Ratio
4.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.52M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47M | 5.48M | - |
| Dec 31, 2024 | -3.02M | -2.72M | - |
| Dec 31, 2023 | -292.00K | -1.20M | - |
| Dec 31, 2022 | 907.00K | -690.00K | -43.21% |
| Dec 31, 2021 | 1.60M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Together Pharma | 109.63M |
| Evogene | 12.28M |
| Clal Biotechnology Industries | 11.55M |
| Identi Healthcare | 10.93M |